Developing
a cancer theranostic nanoplatform with diagnosis and
treatment capabilities to effectively treat tumors and reduce side
effects is of great significance. Herein, we present a drug delivery
strategy for photosensitizers based on a new liquid metal nanoplatform
that leverages the tumor microenvironment to achieve photodynamic
therapeutic effects in pancreatic cancer. Eutectic gallium indium
(EGaIn) nanoparticles were successfully conjugated with a water-soluble
cancer targeting ligand, hyaluronic acid, and a photosensitizer, benzoporphyrin
derivative, creating EGaIn nanoparticles (EGaPs) via a simple green
sonication method. The prepared sphere-shaped EGaPs, with a core–shell
structure, presented high biocompatibility and stability. EGaPs had
greater cellular uptake, manifested targeting competence, and generated
significantly higher intracellular ROS. Further, near-infrared light
activation of EGaPs demonstrated their potential to effectively eliminate
cancer cells due to their single oxygen generation capability. Finally,
from in vivo studies, EGaPs caused tumor regression
and resulted in 2.3-fold higher necrosis than the control, therefore
making a good vehicle for photodynamic therapy. The overall results
highlight that EGaPs provide a new way to assemble liquid metal nanomaterials
with different ligands for enhanced cancer therapy.